logo
Select company
Select metric
3.33%Cash to Assets Ratio
VS
Market
27
Sector
8
Industry
2
History
3
$ 26.83Close
$ 15.13 - $ 28.76 52-Week Range
Ticker Information

Ticker

CLDX

Company Name

CELLDEX THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

CELLDEX THERAPEUTICS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

CLDX - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 692.41M$ 23.04M3.33%
3/31/2025$ 739.47M$ 17.14M2.32%
12/31/2024$ 792.34M$ 28.36M3.58%
9/30/2024$ 823.18M$ 36.4M4.42%
6/30/2024$ 845.59M$ 42.74M5.05%
3/31/2024$ 868.85M$ 115.08M13.24%
12/31/2023$ 465.63M$ 34.81M7.48%
9/30/2023$ 280.26M$ 21.13M7.54%
6/30/2023$ 299.31M$ 28.22M9.43%
3/31/2023$ 324.52M$ 54.12M16.68%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • CELLDEX THERAPEUTICS INC's latest trailing twelve months (TTM) Cash to Assets stands at 7.1%.
  • Over the past 5 years, CELLDEX THERAPEUTICS INC's average Cash to Assets has been 10.13%.
  • The median Cash to Assets for CELLDEX THERAPEUTICS INC during this period was 7.51%
  • CELLDEX THERAPEUTICS INC reached its highest Cash to Assets over the past 5 years at 31.64%.
  • The lowest Cash to Assets recorded by CELLDEX THERAPEUTICS INC in the same timeframe 2.32%

CELLDEX THERAPEUTICS INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
LENZ : LENZ THERAPEUTICS INC 17.36%PRAX : PRAXIS PRECISION MEDICINES INC 34.76%IDYA : IDEAYA BIOSCIENCES INC 11.09%DNTH : DIANTHUS THERAPEUTICS INC 4.06%PRME : PRIME MEDICINE INC 24.19%TSHA : TAYSHA GENE THERAPIES INC 94.61%PGEN : PRECIGEN INC 13.5%UPB : UPSTREAM BIO INC 10.86%VRDN : VIRIDIAN THERAPEUTICS INC 20.15%JANX : JANUX THERAPEUTICS INC 5.16%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for CELLDEX THERAPEUTICS INC is calculated as follows: CashnEq [ $ 18.15M ] / Assets [ $ 255.77M ]
(=) Cash to Assets [ 7.1% ]

CLDX - Cash to Assets Ratio, Last 5 years

2.32%

Minimum

Mar 31, 2025

31.64%

Maximum

Mar 31, 2021

10.13%

Average

7.51%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.84% with a standard deviation of 9.62%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.95K
min0%
max40.92%
average9.84%
median6.44%
std9.62%